An envelope <a href="https://www.jaguared.com/index.php/price-chopper-pharmacy-new-york-24df.pdf#relative">spelling for prescription drugs</a>  Moderately diversified portfolio: PREIT's portfolio consists of three hospitals in Singapore, 32* nursing homes and one pharmaceutical product-distributing and-manufacturing facility (P-Life Matsudo) in Japan, and seven strata titled units at Gleneagles Intan Medical Centre Kuala Lumpur as of end-2012. The Singapore and Malaysia portfolio generated about 61.5% of PREIT's FY12 revenues and 63.4% of its net property income (NPI). The nursing homes and P-Life Matsudo in Japan generated 38.5% of revenues and 36.6% of NPI which provides diversification benefits to the pure-play Singaporean nursing home assetsStrong sponsor: IHH Healthcare Berhad (IHH), an investment holding company, which owns a 35.8% stake in PREIT, strengthens the latter's credit profile. IHH has a strong financial risk profile in its own right and its credit profile benefits from a 45% interest held by its principal sponsor, the Malaysian sovereign wealth fund, Khazanah. IHH's healthcare portfolio potentially gives PREIT the opportunity to grow through asset injections.